Table 3.
Correlation among apoptotic markers, disease activity, and levels of autoantibodies in lupus patients
| SLEDAI2k | c3 | c4 | a-ro | a-ro52 | a-ro60 | a-la | a-mi2 | ||
|---|---|---|---|---|---|---|---|---|---|
| (7AAD + annexinV) of WBC (%) |
r |
0.14 |
-0.3 |
-0.19 |
.513* |
0.29 |
0.41 |
.439* |
.492* |
|
p value |
0.54 |
0.17 |
0.39 |
0.01 |
0.17 |
0.05 |
0.04 |
0.02 |
|
| (7AAD + annexinV) of Granulocyte (%) |
r |
0.18 |
-.460* |
-0.2 |
0.33 |
0.2 |
0.32 |
0.33 |
0.3 |
|
p value |
0.42 |
0.03 |
0.37 |
0.13 |
0.36 |
0.13 |
0.13 |
0.16 |
|
| (7AAD + annexinV) of CD8 (+)(%) |
r |
-0.06 |
0.35 |
.636* |
-0.07 |
0.07 |
-0.21 |
-0.09 |
-0.11 |
|
p value |
0.87 |
0.33 |
0.04 |
0.85 |
0.85 |
0.57 |
0.8 |
0.77 |
|
| APO2.7 of CD4(+)(%) |
r |
0.3 |
0.17 |
0.05 |
-.684* |
-.717* |
-0.62 |
-0.57 |
-0.24 |
|
p value |
0.43 |
0.67 |
0.9 |
0.04 |
0.03 |
0.08 |
0.11 |
0.54 |
|
| APO2.7 of CD19 (+)(%) |
r |
.793* |
-0.45 |
-0.48 |
0.32 |
0.34 |
0.29 |
0.4 |
-0.07 |
|
p value |
0.01 |
0.22 |
0.19 |
0.4 |
0.37 |
0.45 |
0.28 |
0.86 |
|
| SLEDAI2k |
r |
X |
-0.35 |
-.508* |
0.3 |
0.23 |
.407* |
0.24 |
0.21 |
| p value | 0.1 | 0.01 | 0.15 | 0.29 | 0.05 | 0.25 | 0.32 |
Note: *, p<0.05.
Abbreviations: R Correlation coefficient, A-ro Anti-Ro52/60, A-ro52 Anti-Ro 52 kDa, A-ro60 Anti-Ro 60 kDa, A-la Anti-La, A-mi2 Anti-Mi-2, WBC White blood cells or leukocytes, 7-AAD 7-amino-actinomycin D, SLEDAI-2 K Systemic lupus erythematosus disease activity index 2000.